Skip to content
Maui Sky – Lifestyle
Author:
Actimed Therapeutics
Actimed Therapeutics Reacquires Global Rights to S-oxprenolol, Broadening Pipeline Opportunity
August 6, 2026
Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman
July 30, 2026